Short interest in Cartesian Therapeutics Inc (NASDAQ:RNAC) decreased during the last reporting period, falling from 1.86M to 1.83M. This put 11.47% of the company's publicly available shares short.

Short interest for Cartesian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cartesian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 96.57K shares traded per day, it would take 18.95 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.